Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy

Fibroblast growth factor 23 (FGF-23) rises progressively in chronic kidney disease and is associated with adverse cardiovascular outcomes. FGF-23 putatively induces volume retention by upregulating the sodium-chloride cotransporter (NCC). We studied whether, conversely, interventions in volume statu...

Descripción completa

Detalles Bibliográficos
Autores principales: Humalda, Jelmer K., Seiler-Mußler, Sarah, Kwakernaak, Arjan J., Vervloet, Marc G., Navis, Gerjan, Fliser, Danilo, Heine, Gunnar H., de Borst, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120892/
https://www.ncbi.nlm.nih.gov/pubmed/27861335
http://dx.doi.org/10.1097/MD.0000000000005003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120892/
https://www.ncbi.nlm.nih.gov/pubmed/27861335
http://dx.doi.org/10.1097/MD.0000000000005003

Ejemplares similares